This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Masseno, V.
Right arrow Articles by Nzila, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Masseno, V.
Right arrow Articles by Nzila, A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, July 2009, p. 3131-3134, Vol. 53, No. 7
0066-4804/09/$08.00+0     doi:10.1128/AAC.01689-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

In Vitro Chemosensitization of Plasmodium falciparum to Antimalarials by Verapamil and Probenecid{triangledown}

Victor Masseno,1 Steven Muriithi,1 and Alexis Nzila1,2*

Kenya Medical Research Institute/Wellcome Trust Collaborative Research Program, P.O. Box 230, 80108, Kilifi, Kenya,1 University of Oxford, Nuffield Department of Medicine, John Radcliffe Hospital, Oxford, United Kingdom2

Received 22 December 2008/ Returned for modification 14 March 2009/ Accepted 5 April 2009

We tested the effect of probenecid and verapamil in chemosensitizing Plasmodium falciparum to 14 antimalarials using the multidrug-resistant strain V1S and the drug-sensitive 3D7. Verapamil chemosensitizes V1S to quinine and chloroquine. Interestingly, probenecid profoundly chemosensitizes V1S to piperaquine. Thus, probenecid could be used to increase piperaquine efficacy in vivo.

* Corresponding author. Mailing address: Kenya Medical Research Institute/Wellcome Trust Collaborative Research Program, P.O. Box 230, 80108 Kiilfi, Kenya. Phone: 254-41-522535. Fax: 254-41-522390. E-mail: anzila{at}kilifi.kemri-wellcome.org

{triangledown} Published ahead of print on 13 April 2009.

Antimicrobial Agents and Chemotherapy, July 2009, p. 3131-3134, Vol. 53, No. 7
0066-4804/09/$08.00+0     doi:10.1128/AAC.01689-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.





Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»